Article Text

Download PDFPDF
The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases
  1. H Senzaki
  1. Correspondence to:
    Prof. Associate H Senzaki
    Department of Pediatric Cardiology, Saitama Heart Institute, Saitama Medical University Hospital, 38 Morohongo, Moroyama, Saitama 350-0495, Japan; hsenzaki{at}


Kawasaki disease is an acute inflammatory syndrome that takes the form of systemic vasculitis, and predominantly affects children. Important complications of this disease are coronary artery dilation and aneurysm formation. Recent studies indicate that Kawasaki disease patients have elevated expression, activity, or protein levels of matrix metalloproteinases (MMPs), and suggest that imbalances in MMPs or MMP/tissue inhibitor of MMP (TIMP) play important pathophysiological roles in the development of coronary artery lesions in this disease. However, it remains unclear whether MMP activities at the site of coronary artery lesions are indeed increased. Further studies on the effects of MMP inhibition on coronary outcome are needed to define the roles of MMPs and TIMPs in the formation of coronary artery lesions in Kawasaki disease; findings of such studies may support the use of MMP inhibitors for the prevention of coronary artery complications in patients with this disease.

  • CAL, coronary artery lesion
  • IVGG, intravenous gammaglobulin
  • MMP, metalloproteinase
  • TIMP, tissue inhibitor of MMP
  • Kawasaki disease
  • coronary artery aneurism
  • matrix metalloproteinases
  • pathophysiology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Précis
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
  • Atoms
    Howard Bauchner